{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05676476",
            "orgStudyIdInfo": {
                "id": "1K23HL159331",
                "type": "NIH",
                "link": "https://reporter.nih.gov/quickSearch/1K23HL159331"
            },
            "secondaryIdInfos": [
                {
                    "id": "1K23HL159331",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1K23HL159331"
                }
            ],
            "organization": {
                "fullName": "University of Alabama at Birmingham",
                "class": "OTHER"
            },
            "briefTitle": "The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.",
            "officialTitle": "The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.",
            "acronym": "Achieve",
            "therapeuticArea": [
                "Women's Health",
                "Cardiovascular",
                "Other"
            ],
            "study": "the-achieve-trial-achieving-longer-gestation-in-preeclampsia-via-antihypertensive-therapy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-02-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-03",
            "studyFirstSubmitQcDate": "2023-01-04",
            "studyFirstPostDateStruct": {
                "date": "2023-01-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Rachel Sinkey",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "University of Alabama at Birmingham"
            },
            "leadSponsor": {
                "name": "University of Alabama at Birmingham",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The Achieve Trial is a randomized clinical trial to test whether lowering blood pressure to less than 140/90 mmHg in women with hypertensive disorders of pregnancy will prolong pregnancy.",
            "detailedDescription": "Hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia, are characterized by new onset high blood pressure in pregnancy and constitute a major cause of maternal and perinatal morbidity and mortality; severe hypertension (blood pressure \u2265160/110 mmHg) is a common trigger for antihypertensive treatment and preterm delivery. We propose a clinical trial that will test whether lowering the blood pressure in women with hypertensive disorders of pregnancy at \\<36 weeks' gestation to \\<140/90 mmHg will prolong pregnancy and, therefore, improve maternal and fetal/neonatal outcomes. Data generated in this study, along with knowledge and skills acquired by the candidate in the complementary career development plan, will facilitate an independent research career focused on hypertension and cardiovascular disease in pregnancy."
        },
        "conditionsModule": {
            "conditions": [
                "Preeclampsia",
                "Gestational Hypertension",
                "Hypertensive Disorder of Pregnancy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 132,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Intervention",
                    "type": "EXPERIMENTAL",
                    "description": "Antihypertensive treatment for a BP goal of less than 140/90 mmHg",
                    "interventionNames": [
                        "Drug: Antihypertensive treatment"
                    ]
                },
                {
                    "label": "Usual Care",
                    "type": "NO_INTERVENTION",
                    "description": "Antihypertensive treatment only if BP \u2265 160/110 mmHg"
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Antihypertensive treatment",
                    "description": "Antihypertensive treatment to goal of less than 140/90 mmHg",
                    "armGroupLabels": [
                        "Intervention"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Mean number of days from randomization to delivery",
                    "description": "Duration of prolongation of pregnancy",
                    "timeFrame": "From randomization to delivery, up to 14 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Perinatal morbidity",
                    "description": "Composite of NICU admission \u22652 days, bronchopulmonary dysplasia, necrotizing enterocolitis, intraventricular hemorrhage, retinopathy of prematurity, or fetal or newborn death within 6 weeks after birth; individual elements of the composite, the frequency of small for gestational age neonates, birthweight.",
                    "timeFrame": "6 weeks"
                },
                {
                    "measure": "Neonatal healthcare utilization",
                    "description": "NICU and hospital length of stay",
                    "timeFrame": "6 weeks"
                },
                {
                    "measure": "Maternal morbidity",
                    "description": "Composite of severe hypertension, pulmonary edema, heart failure, eclampsia, stroke, liver dysfunction, acute renal failure, thrombocytopenia, abruption, ICU admission, postpartum hospital readmission for hypertension management, or death within 6 weeks of delivery; individual elements of the composite.",
                    "timeFrame": "From randomization to 6 weeks after delivery, up to 20 weeks"
                },
                {
                    "measure": "Maternal healthcare utilization",
                    "description": "Antepartum and postpartum hospital length of stay, ICU admission, postpartum readmission.",
                    "timeFrame": "From randomization to 6 weeks after delivery, up to 20 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Pregnant women\n* Gestational age: 23 weeks, 0 days to 35 weeks, 6 days\n* Hypertensive disorder of pregnancy including gestational hypertension or preeclampsia, the non-severe form at enrollment, which is called without severe features by the American College of Obstetricians and Gynecologists.\n* No evidence of the severe form of preeclampsia, termed severe features, as outlined in maternal exclusions\n* No indication for delivery at the time of enrollment.\n* Planned expectant management at time of enrollment\n* Singleton or dichorionic twin gestation, defined at and beyond 14 weeks gestation. (A pregnancy complicated by a vanishing twin in the first trimester defined as less than 14 weeks gestation will be eligible.)\n* Prenatal care, or another healthcare visit with a documented blood pressure, at less than 21 weeks gestation\n* Intact membranes\n\nExclusion Criteria:\n\n* Preeclampsia with severe features, defined per ACOG as:\n* Systolic blood pressure of 160 mm Hg or more, or diastolic blood pressure of 110 mm Hg or more on two occasions at least 4 hours apart (unless antihypertensive therapy is initiated before this time)\n* Thrombocytopenia defined as: lower than 100 x 10e9 platelets/L\n* Impaired liver function that is not accounted for by alternative diagnoses and as indicated by abnormally elevated blood concentrations of liver enzymes (to more than twice the upper limit normal concentrations), or by severe persistent right upper quadrant or epigastric pain unresponsive to medications\n* Renal insufficiency (serum creatinine concentration more than 1.1 mg/dL or a doubling of the serum creatinine concentration in the absence of other renal disease)\n* Pulmonary edema\n* New-onset headache unresponsive to medication and not accounted for by alternative diagnoses\n* Visual disturbances\n* Underlying renal dysfunction defined as, presenting the following parameters prior to 20 weeks gestation: baseline creatinine, equal to or higher than, 1.2 mg/dL Or proteinuria: defined as presenting protein in urine, equal to or higher than, 300 mg/24 hours or protein/creatinine ratio, equal to or higher than, 0.3 or Urine dipstick reading of greater than or equal to 2 at baseline and in the absence of a urinary tract infection\n* Stage 2 chronic hypertension\n* Contraindications to labetalol and nifedipine XL according to the FDA package insert\n* Patient unable to or unwilling to adhere to management recommendations\n* Fetal Reasons for Study Ineligibility:\n* Fetal growth restriction (lower than 10th percentile) at enrollment, based on an ultrasound within 3 weeks prior to enrollment\n* Oligohydramnios defined by amniotic fluid deepest vertical pocket \\<2 cm based on an ultrasound within the 48 hours prior to enrollment\n* Known major structural or chromosomal abnormality",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "14 Years",
            "maximumAge": "49 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rachel Sinkey, MD",
                    "role": "CONTACT",
                    "phone": "205-934-5611",
                    "email": "rsinkey@uabmc.edu"
                },
                {
                    "name": "Alan Tita, MD",
                    "role": "CONTACT",
                    "phone": "205-934-5611",
                    "email": "atita@uabmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Rachel Sinkey, MD",
                    "affiliation": "University of Alabama at Birmingham",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama at Birmingham",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35233",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rachel Sinkey",
                            "role": "CONTACT",
                            "phone": "205-934-5611",
                            "email": "rsinkey@uabmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "29384983",
                    "type": "BACKGROUND",
                    "citation": "Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S, Frick G, Friedman B, Grassl T, Ichikawa T, Ioannidis JP, Lacy P, McManus R, Murray A, Myers M, Palatini P, Parati G, Quinn D, Sarkis J, Shennan A, Usuda T, Wang J, Wu CO, O'Brien E. A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement. J Hypertens. 2018 Mar;36(3):472-478. doi: 10.1097/HJH.0000000000001634."
                },
                {
                    "pmid": "32852691",
                    "type": "BACKGROUND",
                    "citation": "Sinkey RG, Battarbee AN, Bello NA, Ives CW, Oparil S, Tita ATN. Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines. Curr Hypertens Rep. 2020 Aug 27;22(9):66. doi: 10.1007/s11906-020-01082-w."
                },
                {
                    "pmid": "33004135",
                    "type": "BACKGROUND",
                    "citation": "Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Oct 6;76(14):1690-1702. doi: 10.1016/j.jacc.2020.08.014."
                },
                {
                    "pmid": "31715148",
                    "type": "BACKGROUND",
                    "citation": "Battarbee AN, Sinkey RG, Harper LM, Oparil S, Tita ATN. Chronic hypertension in pregnancy. Am J Obstet Gynecol. 2020 Jun;222(6):532-541. doi: 10.1016/j.ajog.2019.11.1243. Epub 2019 Nov 9."
                },
                {
                    "pmid": "26551272",
                    "type": "BACKGROUND",
                    "citation": "SPRINT Research Group; Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9. Erratum In: N Engl J Med. 2017 Dec 21;377(25):2506. doi: 10.1056/NEJMx170008."
                },
                {
                    "pmid": "29229741",
                    "type": "BACKGROUND",
                    "citation": "Bello NA, Woolley JJ, Cleary KL, Falzon L, Alpert BS, Oparil S, Cutter G, Wapner R, Muntner P, Tita AT, Shimbo D. Accuracy of Blood Pressure Measurement Devices in Pregnancy: A Systematic Review of Validation Studies. Hypertension. 2018 Feb;71(2):326-335. doi: 10.1161/HYPERTENSIONAHA.117.10295. Epub 2017 Dec 11."
                },
                {
                    "pmid": "31268860",
                    "type": "BACKGROUND",
                    "citation": "Sinkey RG, Oparil S. Lower Blood Pressure Thresholds Raise the Bar in Pregnancy. Circ Res. 2019 Jul 5;125(2):195-197. doi: 10.1161/CIRCRESAHA.119.315384. Epub 2019 Jul 3. No abstract available. Erratum In: Circ Res. 2020 Mar 13;126(6):e30. doi: 10.1161/RES.0000000000000329."
                },
                {
                    "pmid": "30575675",
                    "type": "BACKGROUND",
                    "citation": "ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019 Jan;133(1):1. doi: 10.1097/AOG.0000000000003018."
                },
                {
                    "pmid": "22617589",
                    "type": "BACKGROUND",
                    "citation": "Myatt L, Clifton RG, Roberts JM, Spong CY, Hauth JC, Varner MW, Thorp JM Jr, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Iams JD, Sciscione A, Harper M, Tolosa JE, Saade G, Sorokin Y, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol. 2012 Jun;119(6):1234-42. doi: 10.1097/AOG.0b013e3182571669."
                },
                {
                    "pmid": "22996099",
                    "type": "BACKGROUND",
                    "citation": "Myatt L, Clifton RG, Roberts JM, Spong CY, Hauth JC, Varner MW, Wapner RJ, Thorp JM Jr, Mercer BM, Grobman WA, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Harper M, Tolosa JE, Saade G, Sorokin Y, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population. Obstet Gynecol. 2012 Oct;120(4):815-22. doi: 10.1097/AOG.0b013e31826af7fb."
                },
                {
                    "pmid": "31487273",
                    "type": "BACKGROUND",
                    "citation": "Petersen EE, Davis NL, Goodman D, Cox S, Syverson C, Seed K, Shapiro-Mendoza C, Callaghan WM, Barfield W. Racial/Ethnic Disparities in Pregnancy-Related Deaths - United States, 2007-2016. MMWR Morb Mortal Wkly Rep. 2019 Sep 6;68(35):762-765. doi: 10.15585/mmwr.mm6835a3."
                },
                {
                    "pmid": "35363951",
                    "type": "BACKGROUND",
                    "citation": "Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson K, Haas DM, Plante L, Metz T, Casey B, Esplin S, Longo S, Hoffman M, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey H, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Kinzler W, Su E, Krishna I, Nguyen N, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Harper L, Ambalavanan N, Geller NL, Oparil S, Cutter GR, Andrews WW; Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022 May 12;386(19):1781-1792. doi: 10.1056/NEJMoa2201295. Epub 2022 Apr 2."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014115",
                    "term": "Toxemia"
                },
                {
                    "id": "D000011225",
                    "term": "Pre-Eclampsia"
                },
                {
                    "id": "D000046110",
                    "term": "Hypertension, Pregnancy-Induced"
                },
                {
                    "id": "D000006973",
                    "term": "Hypertension"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "asFound": "Hypertensive Disorders",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16869",
                    "name": "Toxemia",
                    "asFound": "Hypertensive Disorders of Pregnancy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14106",
                    "name": "Pre-Eclampsia",
                    "asFound": "Preeclampsia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25635",
                    "name": "Hypertension, Pregnancy-Induced",
                    "asFound": "Gestational Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20864",
                    "name": "Sepsis",
                    "relevance": "LOW"
                },
                {
                    "id": "M7633",
                    "name": "Eclampsia",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2019",
                    "name": "Eclampsia",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "asFound": "90%",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}